Study of Dietary Fatty acids, Blood Fatty Acid Composition, and Immune Parameters in Atopic Dermatitis Patients

아토피 피부염 환자의 지방산 섭취와 혈중 지방산 조성 및 면역 지표에 관한 연구

  • Chung Yun Mi (Department of Medical Nutrition, Graduate School of East-West Medical Science Kyung Hee University) ;
  • Kim Sujung (Department of Medical Nutrition, Graduate School of East-West Medical Science Kyung Hee University) ;
  • Kim Nack-In (Department of Dermatology, College of Medicine, Kyung Hee University) ;
  • Lee Eun-Young (Research Institute of Clinical Nutrition, Kyung Hee University) ;
  • Choue Ryowon (Department of Medical Nutrition, Graduate School of East-West Medical Science Kyung Hee University, Research Institute of Clinical Nutrition)
  • 정윤미 (경희대학교 동서의학대학원 의학영양학과) ;
  • 김수정 (경희대학교 동서의학대학원 의학영양학과) ;
  • 김낙인 (경희대학교 의과대학 피부과학교실) ;
  • 이은영 (경희대학교 임상영양연구소) ;
  • 조여원 (경희대학교 동서의학대학원 의학영양학과, 경희대학교 임상영양연구소)
  • Published : 2005.09.01

Abstract

The prevalence of atopic dermatitis (AD) continues to rise in industrialized countries related to Western lifestyle, including dietary habits, especially imbalance of intake of dietary fatty acids. The purpose of this study was to evaluate the dietary fatty acids and the assess the blood fatty acid composition and immune parameters in AD patients. AD (n = 50) patients and gender ${\cdot}$ age matched healthy controls (HC) were studied in case-control clinical trail. Current fatty acids intake status was determined by 3-day food record method. Blood sample were collected from 30 subjects in each group and blood fatty acid composition and immune parameters were analysed. AD patients consumed less PUFA and their n-6/n-3 PUFA ratio was higher than that of HC. Both the ratios of PUFA and MUFA were positively correlated with SCORAD in AD patients (p < 0.05). In the AD patients, there were abnormalities in the fatty acid composition of the RBC and WBC, SFA being significantly high and most n-3 PUFA being significantly low. Moreover, both the ratios of EPA and DHA in WBC were negatively correlated with dietary n-6/n-3 PUFA ratio in AD patients (p < 0.05). Serum total IgE and IL-4 levels of AD patients increased significantly compared with the levels of HC (p < 0.01). Ratios of monocyte and eosinophil in WBC of AD patients increased significantly compared with the levels of HC including total WBC count (p < 0.01), and ratios of Iymphocyte and basophil in WBC of AD patients decreased significantly compared with the levels of HC (p < 0.05). Moreover, the ratios of eosinophil in WBC were positively correlated with dietary P/M ratio (p < 0.05), and the ratios of monocyte in WBC were positively correlated with n-6/n-3 PUFA ratio (p < 0.05) in AD patients. This results indicated that AD patients had significantly high intake of dietary n-6/n-3 PUFA compared with HC. Imbalance of intake of dietary fatty acids affected fatty acid compositions in the RBC and WBC, and these lead to immune imbalance and grow worse of AD.

Keywords

References

  1. Yoon SP. The Environment and Lifestyles of Atopic ennatitis Patients. Korean J Dermatol 37 (8): 983-991, 1999
  2. Rothe MJ, Grant-Kels JM. Atopic qennatitis: an update. J Am Acad Dermatol 35: 1-13, 1996 https://doi.org/10.1016/S0190-9622(96)90486-7
  3. McNally NJ, Williams HC, Phillilps DR. Atopic eczema and domestic water hardness. Lancet 352: 527-531, 1998 https://doi.org/10.1016/S0140-6736(98)01402-0
  4. Solvoll K, Soyland E, Sandstad B, Drevon CA. Dietary habits among patients with atopic dennatitis. Eur J Clin Nutr 54 (2) : 93-97,2000 https://doi.org/10.1038/sj.ejcn.1600901
  5. Trak-Fellenneier MA, Brasche S, Winkler G, Koletzko B, Heinrich J. Food and fatty acid intake and atopic disease in adults. Eur Respir J 23 (4): 575-582, 2004 https://doi.org/10.1183/09031936.04.00074404
  6. Dunder T. Diet, serum fatty acids, and atopic diseases in childhood. Allergy 56: 425-428, 2001 https://doi.org/10.1034/j.1398-9995.2001.056005425.x
  7. Wakai K, Okamoto K, Tamakoshi A, Lin Y, Nakayama T, Ohno Y. Seasonal allergic rllinoconjunctivitis and fatty acid intake: a cross-sectional study in Japan. Ann Epidemiol 11: 59-64, 2001 https://doi.org/10.1016/S1047-2797(00)00182-4
  8. Oddy WH, Klert NH, Kendall GE. Ratio of omega-6 to omega-3 fatty acids and children asthma. J Asthma 41 (3): 319-326, 2004 https://doi.org/10.1081/JAS-120026089
  9. Manku MS, Horrobin DF, Morse NL, Wright S, Burton JL. Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol 110: 643-648, 1984 https://doi.org/10.1111/j.1365-2133.1984.tb04698.x
  10. Biagi PL, Hrelia S, Celadon M. Erythrocyte membrane fatty acid composition in the children with atopic dermatitis compared to age-matched controls. Acta Pediatr 82: 789-790, 1993 https://doi.org/10.1111/j.1651-2227.1993.tb12559.x
  11. Nagel G, Nieters A, Becker N, Linseisen J. The influence of the dietary intake of fatty acids and antioxidants on hay fever in adults. Allergy 58 (12): 1277-1284,2003 https://doi.org/10.1046/j.1398-9995.2003.00296.x
  12. Simopoulos AP. Omega n-3-fatty acids in health and disease and in growth and development. Am J Clin Nutr 54: 438-463, 1991
  13. Sanders TA. Polysaturated fatty acids in the food chain in Europe. Am J Clin Nutr 71 (1): 176S-178S, 2000
  14. Calder PC. Polysaturated fatty acids, inflammation and immunity. Lipids 36: 1007-1024,2001 https://doi.org/10.1007/s11745-001-0812-7
  15. Oliwiecki S. Levels of essential and other fatty acids in plasma and red cell phospholipids from normal controls and patients with atopic eczema. Acta Derm Venereol 71 (3): 224-228, 1991
  16. Sauerwald TU, Hachey DL, Jensen CL, Heird WC. New insights into the metabolism of long chain polyunsaturated fatty acids during infancy. Eur J Med Res 2 (2): 88-92, 1997
  17. Melnik BC, Plewig G. Atopy: a prostaglandin E precursor- and receptor-dependent defect in T-cell maturation and function? Br J Dennatol 123: 126-128, 1990
  18. Calder PC, Miles EA. Fatty acids and atopic disease. Pediatric Allergy Immunol 11 (13): 29S, 2000
  19. Black PN, Sharpe S. Dietary fat and asthma: is there a connection? Eur Respir J 10: 6-12, 1997 https://doi.org/10.1183/09031936.97.10010006
  20. Hodge L, Peat JK, Salome C. Increased consumption of polyunsaturated oils may be a cause of increased prev-alence of childhood asthma. Aust NZ J Med 24: 727, 1994
  21. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clones. I. Definition according to profiles of Iymphokine activities and secreted proteins. J Immunol 136: 234-857, 1986
  22. William WB. Mechanisms and advences in allergic disease. J allergy Clin Immunol 105: S593-S598, 2000 https://doi.org/10.1067/mai.2000.106149
  23. Kapsenberg ML, Wierenga EA, Stiekema FEM. Thl lymphokine production profiles of nickel-specific CD4+ lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 98: 59-63, 1992 https://doi.org/10.1111/1523-1747.ep12494841
  24. Mark R, Kilkenny M, Plunkett A, Merlin K. The prevalence of common skin conditions in Australian scool student. Br J Dermatol 140: 468-473, 1999 https://doi.org/10.1046/j.1365-2133.1999.02711.x
  25. Hanifm JM. Immunologic aspects of atopic dermatitis. Dermatol Clin 8: 747-750,1990
  26. Jones HE. Atopic disease and serum immunoglobulin-E. Br J Dermatol 92: 17-25, 1975 https://doi.org/10.1111/j.1365-2133.1975.tb03028.x
  27. Hanifin JM, Rajka G. Diagnostic features of Atopic Dermatitis. Acta Dermatovener (suppI)92: 44-47,1980
  28. Kunz B. Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 195: 10-19, 1997
  29. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Pysiol 37: 911-917, 1959 https://doi.org/10.1139/o59-099
  30. Morrison WR, Smith LM. Precipitation fatty acid methylesters and dimethylacetals from lipids with boron fluoridemethanol. J Lipid Res 5: 600-608, 1964
  31. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 11: 648-656, 1999 https://doi.org/10.1016/S0952-7915(99)00032-1
  32. Ruxton CH, Reed SC, Simpson MJ, Millington KJ. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 17 (5) : 449-459, 2004 https://doi.org/10.1111/j.1365-277X.2004.00552.x
  33. Wahrburg U. What are the health effects of fat? Eur J Nutr 43 (Suppl 1) : I/6-11, 2004
  34. Simopoulos AP. The importance of the ratio of omega-6/omega3 essential fatty acids. Biomed Pharmacother 56 (8): 365-379, 2002 https://doi.org/10.1016/S0753-3322(02)00253-6
  35. WHO. Diet, nutrition and the prevention of chronic diseases. Report of the joint WHO/FAO expert consultation, 2003
  36. Schafer T. Intake of unsaturated fatty acids and HDL cholesterol levels are associated with manifestations of atopy in adults. Clin Exp Allergy 33: 1360-1367, 2003 https://doi.org/10.1046/j.1365-2222.2003.01780.x
  37. Bjorneboe A, Soyland E, Bjorneboe GE, Rajka G, Drevon CA. Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. Br J Dermatol 117 (4): 463-469, 1987 https://doi.org/10.1111/j.1365-2133.1987.tb04926.x
  38. Mayser P, Mayer K, Mahloudjian M, Benzing S, Kramer HJ, Schill WB, Seeger W, Grimminger F. A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis. J Parenter Enteral Nutr 26 (3) : 151-158,2002 https://doi.org/10.1177/0148607102026003151
  39. Ring J, Kunz B. Unsaturated fatty acids in the treatment of atopic eczema. Handbook of atopic eczema. Berlin: Springer, pp.429434, 1991
  40. van Gool CJ, Zeegers MP, Thijs C. Oral essential fatty acid supplementation in atopic dermatitis-a meta-analysis of placebocontrolled trials. Br J Dermatol 150(4): 728-740, 2004 https://doi.org/10.1111/j.0007-0963.2004.05851.x
  41. Dry J, Vincent D. Effect of a fish oil diet on asthma: results of a I-year double-blind study. Int Arch Allergy Appl Immunol 95: 156-157,1991 https://doi.org/10.1159/000235421
  42. Okamoto M, Mitsunobu F, Ashida K, et al. Effects of dietary supplementation with n-3 fatty acids compared with n-6 fatty acids on bronchial asthma. Intern Med 39: 107-111, 2000 https://doi.org/10.2169/internalmedicine.39.107
  43. Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 16: 861-865,2000 https://doi.org/10.1183/09031936.00.16586100
  44. Stenius-Aarniala B, Aro A, Hakulinen A, Ahola I, Seppala E, Vapaatalo H. Evening primose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Ann Allergy 62: 534-537, 1989
  45. Thien FC, Mencia-Huerta JM, Lee TH. Dietary fish oil effects on seasonal hay fever and asthma in pollen-sensitive subjects. Am Rev Respir Dis 147: 1138-1143, 1993
  46. Hodge L, Salome CM, Hughes JM, et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J 11: 361-365, 1998 https://doi.org/10.1183/09031936.98.11020361
  47. Mihrshahi S, Peat JK, Webb K, Oddy W, Marks GB, Mellis CM. CAPS Team. Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age. Pediatr Allergy Immunol 15 (6): 517-522, 2004 https://doi.org/10.1111/j.1399-3038.2004.00187.x
  48. Brown WR, Hansen AE. Arachidonic acid and linoleic acid of serum in normal and eczematous human subject. Pro Soc Exp Biol Med 30: 113-116, 1937
  49. Chung YM, Kim BS, Kim NI, Lee EY, Choue RW. Study of nutritional status, dietary patterns, and dietary quality of atopic deramtitis patients. Korean J Nutrition 38 (6): 419-431, 2005
  50. Peat JK, Berg RH, Green WF, Mellis CM, Leeder SR, Woolcock AJ. Changing prevalence of asthma in Australian children. BMJ 308: 1591-1596,1994
  51. Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-1986. BMJ 300: 1306-1310, 1990 https://doi.org/10.1136/bmj.300.6735.1306
  52. Roberts DCK. Dietary factors in the fall in coronary heart disease mortality. Prostaglandins Leukot Essent Fatty Acids 44: 97-101, 1991 https://doi.org/10.1016/0952-3278(91)90190-G
  53. Heinrich J, Richter K, Frye C, Meyer I, Wolke G, Wjst M. European Community respiratory Health Survey in Adults (ECRHS). Pneumologie 56: 297-303, 2002 https://doi.org/10.1055/s-2002-30699
  54. Zamaria N. Alteration of polyunsaturated fatty acid status and metabolism in health and disease. Reprod Nutr Dev 44 (3) : 273-282,2004 https://doi.org/10.1051/rnd:2004034
  55. Snijdewint FGM, Kalinski P, Wieringa EA. Prostaglandin E2 differentially modulates cytokine secretion profiles in human Thelper lymphocytes. J Immunol 150: 5321-5329, 1993
  56. Gold KN, Weyand CM, Goronzy JJ. Modulation of helper T-cell function by prostaglandins. Arth Rheum 37: 925-933, 1994 https://doi.org/10.1002/art.1780370623
  57. Roper RL, Phipps RP. Prostaglandin E2 and cAMP inhibit Blymphocyte activation and simultaneously promote IgE and IgGl synthesis. J Immunol 149: 2984-2991, 1992
  58. Roper RL, Brown DM, Phipps RP. Prostaglandin E2 promotes B-Iymphocyte Ig isotype switching to IgE. J Immunol 154: 162-170, 1995
  59. Calder PC. Dietary modification of inflanunation with lipids. Proc Nutr Soc 61: 345-358, 2002
  60. Wright S. Essential fatty acids and the skin. British J Dermatol 125: 503-515, 1991 https://doi.org/10.1111/j.1365-2133.1991.tb14786.x
  61. Kang K, Tian R. Atopic dermatitis. An evaluation of clinical and laboratiry findings. Int J Dermatol 26: 27-32, 1987 https://doi.org/10.1111/j.1365-4362.1987.tb04572.x
  62. Stone SP, Muller SA, Gleich GJ. IgE levels in atopic dermatitis. Arch Dermatol 108: 806-811, 1973 https://doi.org/10.1001/archderm.108.6.806
  63. Uehara M, Kimura C. Descendant family history of atopic dermatitis. Acta Derm Venereol (Stockh) 73: 62-63, 1993
  64. Chung JW, Kim HJ, Kim YW, Chang CY. Serum IgE and Peripheral Blood T- Lymphocytes in Parientis with Atopic Dermatitis. Korean Dermatological Association 20: 365-373, 1982
  65. Kim JS, Rhirn KJ, Son SJ. A Study on Serum IgE Levels in Various Dermatoses. Korean Dermatological Association 20: 839843, 1982
  66. Noh GW, Lee KY. Plasma Interferon (IFN) - $\gamma$ , Interleukin (IL)4, IL-5 and IL-10 Concentrations in Atopic Dermatitis. Kor Pediatr Allergy Respir 8 (1) : 72-78, 1998
  67. Jujo K, Renz H, Abe J, Gelfand EW, Leung DYM. Decreased interferon ganuna and increase interleukin-4 production in atopic dermatitis promotes Ig synthesis. J Allergy Clin Immunol 90: 323-332, 1992 https://doi.org/10.1016/S0091-6749(05)80010-7
  68. LeGros GS, Ben-Sasson Z, Seder R, Finkelman FD, Paul WE. Generation of interleukin-4 producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J Exp Med 172: 921-929,1990 https://doi.org/10.1084/jem.172.3.921
  69. Gajewski TF, Joyce J, Fitch FW. Antiproliferative effect of IFN-$\gamma$ in immune regulation. III. Differential selection of Th1 and Th2 murine helper T-Iymphocyte clones using recombinant IL-2 and recombinant IFN- $\gamma$. J Immunol 143: 15-22, 1989
  70. Walker C, Kagi MK, Ingold P, Braun P. Atopic dermatitis: Correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 23: 145-53, 1993 https://doi.org/10.1111/j.1365-2222.1993.tb00310.x
  71. Waller PF. Eosinophilia. J Allergy Clin Immunol 73: 1-11, 1984 https://doi.org/10.1016/0091-6749(84)90474-3
  72. Leiferman KM. Eosinophils in atopic dermatitis. J Allergy Clin Immunol 94(6 Pt 2): 1310-1317, 1994 https://doi.org/10.1016/0091-6749(94)90347-6
  73. Yonsei Univ Wonju Christian Hospital Laboratory Medicine